|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Insu-lin sensitizer and uratemetabolism显示文摘 | Iwatani M Wasada T Iwamoto Y | 2000 | Nippon Rinasho2000，58，4： | 1 |
| 2 | Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages显示文摘 | Dai JH Iwatani Y Ishida T | 2001 | Immunology2001，103，2： | 1 |
| 3 | Functional food products in Japan:A review显示文摘Japan has a long history of using foods with health benefits and Japanese people are well-known for their longevity.In 1991,the Ministry of Health,Labor and Welfare introduced a functional food regulation called“foods for specified health uses”(FOSHU)in Japan.After the introduction of the functional food system,many clinically proven FOSHU products with health benefits have been developed and launched in the market.As a result,the net sales of FOSHU products reached 6.2 billion dollars in 2007.Most of the health claims relate to improving gastro-intestinal health using probiotics.Triglycerides,high blood pressure,high LDL-cholesterol,and high blood glucose are mainly associated with the related health claims.After 2007,the market for FOSHU products was almost saturated.However,a novel functional regulatory system\called“Foods with Function Claims”was established in 2015 based on the Dietary Supplement Health and Education Act system established in the USA.Major health claims in the new regulation system are associated with fatigue,eyes,memory,stress,sleep,joints,blood flow,body temperature,muscles,and Body Mass Index.After the introduction of the new system,the total sales for functional foods including FOSHU products reached 8 billion dollars in 2018.The new functional regulatory system is more flexible in terms of health claims,the protocol for clinical studies,and the required results.Therefore,the market for new regulatory products is still growing.In the present paper,the potential of both regulatory systems and some related issues will be discussed. | Shun Iwatani Naoyuki Yamamoto | 2019 | Food Science and Human Wellness2019，8，2： | 1 |
| 4 | Insulin sensitizer and urate metabolism显示文摘 | Iwatani M Wasada T Iwamoto Y | 2000 | Nippon Rimho2000，58，2： | 1 |
| 5 | Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells显示文摘 | Suzuki A Iwatani H Ito T | 2004 | Kidney Int2004，65，： | 1 |
| 6 | Intrathyroid HLA-DR positive lymphocytes in Hashimotos' disease: Increases in CD8 and Leu7 cells显示文摘 | Aozasa M Amino N Iwatani Y | 1989 | Clin Immunol Immunopathol1989，52，： | 1 |
| 7 | Hematopoietic and non- hematopoieticpotentials of Hoechst (low)/side population- cells isolated from adult rat kidney显示文摘 | Iwatani H Ito T Imai E | 2004 | Kidney Int2004，65，5： | 1 |
| 8 | Metabolic flux analysis in bio-technology processes显示文摘 | IWATANI S YAMADA Y USUDA Y | 2008 | Biotechnology Letters2008，30，5： | 1 |
| 9 | Development of New Hot Rolling Process for Thin Strip Rolling显示文摘 | Shimizhu Y Iwatani J Yamasaki Y | 2000 | Technology Review-Mitsubishi Heavy Industries2000，37，2： | 1 |
| 10 | Treatment of lymphangioma in children:Our experience of 128 cases显示文摘 | Okazaki T Iwatani S Yanai T | 2007 | Journal of Pediatric Surgery2007，42，： | 1 |
| 11 | Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G 显示文摘 | Iwatani Y Chan D S Wang F | 2007 | Nucleic Acids Res2007，35，21： | 1 |
| 12 | Behavior of supercritical CO2injected into porous media containing water显示文摘 | Suekane T Sokawa S Iwatani S | 2005 | Energy2005，30，11： | 1 |
| 13 | Postoperative chemotherapy with a novel oral anticancer drug composed of tegafur,gimeracil and oteracil postassium to curability C scirrhus type gastric cancer显示文摘 | Shimada Y Ohshima T | 2001 | Gan To Kagaku Ryoho2001，28，8： | 1 |
| 14 | An AI tool and its applications to diagnosis problems显示文摘 | Hiroshi NARAZAKI toshiharu IWATANI | 1990 | ISIJ International1990，30，2： | 1 |
| 15 | Structural Insights into HIV-1Vif-APOBEC3FInteraction显示文摘 | Nakashima M Ode H Kawamura T Kitamura S Naganawa Y Awazu H Tsuzuki S Matsuoka K Nemoto M Hachiya A Sugiura W Yokomaku Y Watanabe N Iwatani Y | 2015 | J Virol2015，，： | 1 |
| 16 | Characterization and structure analysis of a novel baeterioein, lacticin Z, produced by Laetoeoeeus laetis QU 14显示文摘 | Iwatani S Zendo T Yoneyama F | 2007 | Bioscience Biotechnology and Biochemistry2007，71，8： | 1 |
| 17 | Formation of porous poly(ethylene-co -vinyl alcohol) membrane via thermally induced phase separation显示文摘 | Matsuyama H Iwatani T Kitamura Y | 2001 | J Appl Polym Sci2001，79，： | 1 |
| 18 | Cyclophosphamide pulse therapy effective for childhood-onset refractory muhiple sclerosis: a case report 显示文摘 | IKEDA T KAGITANI-SHIMONO K IWATANI Y | 2013 | No To Hattatsu2013，45，1： | 1 |
| 19 | Insulin sensitizer and urate metabolism显示文摘 | IWATANI M WASADA T IWAMOTO Y | 2000 | Nippon Rinsho2000，58，2： | 1 |
| 20 | Treatment of lymphangioma in children:our experience of 128 cases显示文摘 | Okazaki T Iwatani S Yanai T | | 0，，02： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员